Evolution of clinical trials in multiple sclerosis
Clinical trials have advanced the treatment of multiple sclerosis (MS) by demonstrating the safety and efficacy of disease-modifying therapies (DMTs). This review discusses major changes to MS clinical trials in the era of DMTs. As treatment options for MS continue to increase, patients in modern MS...
Main Authors: | Yinan Zhang, Amber Salter, Erik Wallström, Gary Cutter, Olaf Stüve |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-02-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286419826547 |
Similar Items
-
Clinical trials in multiple sclerosis: milestones
by: Yinan Zhang, et al.
Published: (2018-07-01) -
Clinical trials in multiple sclerosis: potential future trial designs
by: Navid Manouchehri, et al.
Published: (2019-05-01) -
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
by: Yinan Zhang, et al.
Published: (2020-10-01) -
Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
by: Yinan Zhang, et al.
Published: (2021-03-01) -
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
by: Bardia Nourbakhsh, et al.
Published: (2014-09-01)